triptolide has been researched along with Melanoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Gu, Y; Jiang, L; Liu, J; Tang, X; Wu, X | 1 |
| Du, Y; Gu, Y; Jiang, L; Lang, Y; Li, A; Liu, J; Liu, X; Tang, X; Zhao, Y | 1 |
| Deng, G; Guo, Q; Lin, P; Wang, S; Xia, X; Xu, R | 1 |
| Chen, G; Chen, J; Cheng, X; Du, P; Hu, Q; Hua, ZC; Jiang, W; Liu, X; Qiao, Y; Tang, B; Wei, J; Yang, B; Zhang, X | 1 |
| Chen, T; Ren, Y; Tang, X; Tian, P; Wang, H; Wang, Y; Xin, H; Zhao, X | 1 |
| Chen, G; He, X; Li, J; Liu, B; Lu, A; Lu, C; Zhang, G; Zhang, H | 1 |
| Cao, YP; Li, LJ; Ma, PC; Sun, JF; Tao, Y; Zhang, ML; Zhou, WQ | 1 |
| Chen, YL; Chueh, FS; Chung, JG; Hsu, SC; Hsueh, SC; Ji, BC; Lu, HF; Yang, JS | 1 |
| Chen, YL; Chueh, FS; Chung, JG; Chung, MT; Hsiao, YP; Huang, AC; Hung, FM; Lu, HF; Yang, JS | 1 |
| Chen, J; Guo, Z; Pei, XF; Underhill, CB; Wang, L; Xu, XM; Yang, J; Yang, S; Zhang, L | 1 |
10 other study(ies) available for triptolide and Melanoma
| Article | Year |
|---|---|
Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Diterpenes; Drug Carriers; Drug Liberation; Epoxy Compounds; Exosomes; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Phenanthrenes; RAW 264.7 Cells; S Phase Cell Cycle Checkpoints; TNF-Related Apoptosis-Inducing Ligand | 2021 |
αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma.
Topics: Animals; Cell Line, Tumor; Diterpenes; Epoxy Compounds; Exosomes; Humans; Integrin alphaVbeta3; Integrins; Melanoma; Melanoma, Cutaneous Malignant; Mice; Peptides, Cyclic; Phenanthrenes; Skin Neoplasms; Tissue Distribution | 2022 |
Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Topics: Cell Line, Tumor; Ferroptosis; Humans; Immunotherapy; Lung Neoplasms; Melanoma; Metal-Organic Frameworks; Neoplasms; Pyroptosis; Reactive Oxygen Species | 2023 |
Modulation of
Topics: Animals; Biological Therapy; Combined Modality Therapy; Disease Models, Animal; Diterpenes; Epoxy Compounds; Immunosuppressive Agents; Melanoma; Mice, Inbred C57BL; Necrosis; Neovascularization, Pathologic; Neutrophils; Phenanthrenes; Salmonella; Treatment Outcome; Vascular Endothelial Growth Factor A | 2017 |
Triptolide modulates tumour-colonisation and anti-tumour effect of attenuated Salmonella encoding DNase I.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Deoxyribonuclease I; Disease Models, Animal; Diterpenes; Drug Carriers; Epoxy Compounds; Genetic Vectors; Humans; Melanoma; Mice; Models, Biological; Phenanthrenes; Plasmids; Salmonella; Salmonella Infections; Treatment Outcome; Vaccines, DNA | 2019 |
Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Diterpenes; Down-Regulation; Drugs, Chinese Herbal; Epoxy Compounds; Forkhead Transcription Factors; Interleukin-10; Lymph Nodes; Male; Melanoma; Mice, Inbred C57BL; Phenanthrenes; Phytotherapy; RNA, Messenger; Spleen; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tripterygium; Vascular Endothelial Growth Factor A | 2013 |
Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; bcl-X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Epoxy Compounds; Humans; Melanoma; NF-kappa B; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; S Phase Cell Cycle Checkpoints; Skin Neoplasms | 2012 |
Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.
Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Comet Assay; Diterpenes; DNA Damage; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; DNA-Activated Protein Kinase; DNA-Binding Proteins; Down-Regulation; Epoxy Compounds; Gene Expression; Humans; Melanoma; Phenanthrenes; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2013 |
Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Calcium Signaling; Caspases; cdc25 Phosphatases; Cell Line, Tumor; Cell Shape; Cell Survival; Cyclin E; Diterpenes; Drug Screening Assays, Antitumor; Epoxy Compounds; Humans; Melanoma; Membrane Potential, Mitochondrial; Mitochondria; Oncogene Proteins; Phenanthrenes; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints | 2013 |
Triptolide inhibits the growth and metastasis of solid tumors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Cell Division; Diterpenes; Epoxy Compounds; Female; Humans; Melanoma; Melanoma, Experimental; Mice; Neoplasm Metastasis; Phenanthrenes; Stomach Neoplasms; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |